Cargando...
Pharmacokinetics of Low and Maintenance Dose Valganciclovir in Kidney Transplant Recipients
Valganciclovir is commonly used for cytomegalovirus (CMV) prophylaxis in renal transplant patients. A fixed dose of 900 mg daily is typically recommended, however, there has never been a formal pharmacokinetic study comparing various doses in renal transplant patients. We therefore compared the phar...
Gardado en:
| Main Authors: | , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2008
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2532821/ https://ncbi.nlm.nih.gov/pubmed/18444933 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1600-6143.2008.02220.x |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|